252 related articles for article (PubMed ID: 6787131)
1. Specific reversal of cytolytic T cell-target cell functional binding is induced by free target cells.
Balk SP; Mescher MF
J Immunol; 1981 Jul; 127(1):51-7. PubMed ID: 6787131
[TBL] [Abstract][Full Text] [Related]
2. Specific reversal of cytolytic T lymphocyte--target cell interaction.
Balk SP; Mescher MF
J Supramol Struct Cell Biochem; 1981; 16(1):43-52. PubMed ID: 6795359
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of cytolytic T lymphocyte binding to target cells in suspension.
Balk SP; Walker J; Mescher MF
J Immunol; 1981 Jun; 126(6):2177-83. PubMed ID: 6971889
[TBL] [Abstract][Full Text] [Related]
4. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
5. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
Plata F; Jongeneel V; Cerottini JC; Brunner KT
Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
[TBL] [Abstract][Full Text] [Related]
6. Degradation of specificity in cytolytic T lymphocyte clones. The separate YAC-1-type (NK-like) and P815-type broad specificity killing patterns are both restricted to the larger cells within a clone but may be expressed independently in clones from different mouse strains.
Shortman K; Wilson A
J Immunol; 1986 Aug; 137(3):798-804. PubMed ID: 2424983
[TBL] [Abstract][Full Text] [Related]
7. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response.
Maryanski JL; Van Snick J; Cerottini JC; Boon T
Eur J Immunol; 1982 May; 12(5):401-6. PubMed ID: 6178607
[TBL] [Abstract][Full Text] [Related]
8. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
Germain RN; Williams RM; Benacerraf B
Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
[TBL] [Abstract][Full Text] [Related]
9. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
Maryanski JL; Boon T
Eur J Immunol; 1982 May; 12(5):406-12. PubMed ID: 6178608
[TBL] [Abstract][Full Text] [Related]
10. Competitive inhibition of cytotoxic T lymphocyte-target cell conjugation. A direct evaluation of membrane antigens involved in cell-mediated immunity.
Schick B; Berke G
Transplantation; 1979 Jun; 27(6):365-8. PubMed ID: 111379
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
Bear HD
Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
[TBL] [Abstract][Full Text] [Related]
12. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model.
Soo Hoo W; Lundeen KA; Kohrumel JR; Pham NL; Brostoff SW; Bartholomew RM; Carlo DJ
J Immunol; 1999 Jun; 162(12):7343-9. PubMed ID: 10358185
[TBL] [Abstract][Full Text] [Related]
13. Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815.
Brichard VG; Warnier G; Van Pel A; Morlighem G; Lucas S; Boon T
Eur J Immunol; 1995 Mar; 25(3):664-71. PubMed ID: 7705394
[TBL] [Abstract][Full Text] [Related]
14. Induction and properties of cytotoxic T cells specific for hapten-coupled tumor cells.
Dennert G; Hatlen LE
J Immunol; 1975 Jun; 114(6):1705-12. PubMed ID: 805174
[TBL] [Abstract][Full Text] [Related]
15. T lymphocyte-mediated cytolysis: dissociation of the binding and lytic mechanisms of the effector cell.
Fishelson Z; Berke G
J Immunol; 1978 Apr; 120(4):1121-6. PubMed ID: 305932
[TBL] [Abstract][Full Text] [Related]
16. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and LYT-2,3. I. Increased susceptibility to blocking after papain treatment of target cells.
Gromkowski SH; Heagy W; Sanchez-Madrid F; Springer TA; Martz E
J Immunol; 1983 Jun; 130(6):2546-51. PubMed ID: 6406593
[TBL] [Abstract][Full Text] [Related]
17. Accessory cell requirements for the generation of cytolytic T lymphocytes.
Lutz CT; Fitch FW
J Immunol; 1979 Jun; 122(6):2598-604. PubMed ID: 109533
[TBL] [Abstract][Full Text] [Related]
18. Tumor cell destruction by cytotoxic T lymphocytes: the basis of reduced antitumor cell activity in syngeneic hosts.
Fishelson Z; Berke G
J Immunol; 1981 May; 126(5):2048-52. PubMed ID: 6783702
[TBL] [Abstract][Full Text] [Related]
19. The induction of cytolytic T lymphocytes with syngeneic trinitrophenyl-coupled membranes.
Sherman L; Mescher MF; Burakoff SJ
J Immunol; 1979 Jul; 123(1):501-2. PubMed ID: 312884
[TBL] [Abstract][Full Text] [Related]
20. Generation of cytolytic T lymphocytes in vitro. X. Induction of primary and secondary CTL responses by the mitogen sodium periodate.
Maryanski JL; Cerottini JC; Brunner KT
J Immunol; 1979 Jan; 122(1):342-9. PubMed ID: 84021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
